• D Baschera, C Walter, M Wren, and R Zellweger.
• Department of Orthopaedic and Trauma Surgery, Royal Perth Hospital, North block, Level 5, Wellington Street, 6000, Perth, WA, Australien, dbaschera@bluewin.ch.
• Unfallchirurg. 2014 May 1; 117 (5): 420-7.

BackgroundThe Ilizarov external fixator (IF) is an immediate and definitive treatment option for severe tibial fractures compromised by extensive soft tissue damage. The aim of this study was to assess the general performance of the IF and especially the impact on patient quality of life.MethodA postal questionnaire including an SF-12 health survey and questions about various other aspects of quality of life was sent to all patients who received an IF for primary fracture treatment at a level 1 trauma centre between January 2000 and June 2009.ResultsA total of 48 completed questionnaires were received from patients treated with IF for severe tibial fractures. The median time to removal of the IF was 154 days (range 70-614 days). The mean SF-12 mental component score (MCS) was 52 (SD±12) and the mean physical component score (PCS) was 38 (SD±11). Of the patients 100 % answered that they were either satisfied or very satisfied with the treatment and 91 % would choose the same method of treatment under similar circumstances.ConclusionsThis study demonstrates a high performance of IF in the treatment of severe tibial fractures with compromised soft tissue where more standard forms of treatment are contraindicated.

29 keywords...

hide…